[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Biotwit1 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3350960901.png) @Biotwit1 DKBIO

DKBIO posts on X about acasunlimab, $gmab, mcap, in november the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::3350960901/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3350960901/c:line/m:interactions.svg)

- X Week XX -XX%
- X Month XXXXX +51%
- X Months XXXXX -XX%
- X Year XXXXXX +158%

### Mentions: X [#](/creator/twitter::3350960901/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3350960901/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX +41%
- X Months XX +12%
- X Year XXX +86%

### Followers: XXX [#](/creator/twitter::3350960901/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3350960901/c:line/m:followers.svg)

- X Week XXX -XXXX%
- X Month XXX -XXXX%
- X Months XXX +3.60%
- X Year XXX +26%

### CreatorRank: undefined [#](/creator/twitter::3350960901/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3350960901/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[currencies](/list/currencies)  XX%

**Social topic influence**
[acasunlimab](/topic/acasunlimab) #1, [$gmab](/topic/$gmab) #5, [mcap](/topic/mcap) 20%, [in november](/topic/in-november) 20%, [ben](/topic/ben) 20%, [guess](/topic/guess) 20%, [$zyme](/topic/$zyme) 20%, [ceo](/topic/ceo) XX%

**Top accounts mentioned or mentioned by**
[@theraymyers](/creator/undefined) [@geokoutalidis](/creator/undefined) [@jodmark11](/creator/undefined) [@jacobplieth](/creator/undefined) [@bertrandbio](/creator/undefined) [@bymadeleinea](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"$Gmab Should have kept partnership with Gmab on Acasunlimab. BioNTechs phase X PRESERVE-003 which is assessing CTLA-4 inhibitor gotistobart (also known as BNT316/ONC-393) in non-small cell lung cancer has been put on hold by FDA"  
[X Link](https://x.com/Biotwit1/status/1847382921612841320)  2024-10-18T21:03Z XXX followers, XXX engagements


"@TheRayMyers @geokoutalidis They are lining up Epkinly developing as planned aim to X L DLBCL and FL as well as Rina-s with great data. Look out for acasunlimab data in nsclc in H2. $Gmab seems on track. Current mcap is a joke"  
[X Link](https://x.com/Biotwit1/status/1956068684029411829)  2025-08-14T19:01Z XXX followers, XXX engagements


"@jodmark11 @TheRayMyers @geokoutalidis Merus CRC data in November and likely also Acasunlimab at SITC hs ben mentioned many times by Gmab. Believe there is some 20+ abstracts on Epcoritamab at ASH too. Read the company presentation"  
[X Link](https://x.com/Biotwit1/status/1973028830622429301)  2025-09-30T14:15Z XXX followers, XXX engagements


"@JacobPlieth @BertrandBio @ByMadeleineA $GMAB GEN1046 Acasunlimab news SOON. Something like this. PD-L14-1BB gives costimulation but INCOMPLETE PD-1 blockade. Adding a PD-1 inhibitor fully releases inhibition. Together they provide activation plus costimulation driving durable immunity. Guess U knew this by now :-)"  
[X Link](https://x.com/Biotwit1/status/1975902927891169666)  2025-10-08T12:35Z XXX followers, XXX engagements


"$ZYME good data on FRa ADC ZW191 in gynecological cancer last week. Genmab bought Profound Bio to get hands on Rinatabart Sesutecan Rina-S for $XXX Bn profound Bios FRa ADC. Gmab CEO told media that several BP CEOs called him to congratulate him on the deal = buyers of Zyme 🔥"  
[X Link](https://x.com/Biotwit1/status/1984323682731257949)  2025-10-31T18:16Z XXX followers, XXX engagements